https://givlaari.jp/daily1.0 https://givlaari.jp/about-givlaari/characteristic2022-06-21T00:54Znever https://givlaari.jp/about-givlaari/development-history2022-03-14T08:27Znever https://givlaari.jp/about-givlaari/drug-information2025-10-01T08:54Zmonthly https://givlaari.jp/about-givlaari/mechanism-of-action2021-10-06T14:19Znever https://givlaari.jp/clinical-results/overview2024-07-02T09:13Zyearly https://givlaari.jp/clinical-results/primary-endpoint2022-01-24T05:16Znever https://givlaari.jp/clinical-results/secondary-endpoint2022-01-24T05:17Znever https://givlaari.jp/clinical-results/exploratory-endpoint2022-01-24T05:17Znever https://givlaari.jp/clinical-results/safety2024-07-11T05:36Zyearly https://givlaari.jp/proper-use/pre-administration2023-05-18T03:52Znever https://givlaari.jp/proper-use/administration2023-05-18T03:54Znever https://givlaari.jp/proper-use/precautions2023-05-18T03:55Znever https://givlaari.jp/documents2025-10-09T02:05Zmonthly https://givlaari.jp/sitemap2023-05-24T12:46Znever https://givlaari.jp/patient-support2024-10-25T07:35Zyearly https://givlaari.jp/clinical-results/envision-24m/overview2024-07-05T09:18Zyearly https://givlaari.jp/clinical-results/envision-24m/results2024-07-02T09:37Zyearly https://givlaari.jp/clinical-results/envision-24m/safety2024-07-08T00:54Zyearly